Vaishali Pharma Limited
NSE: VAISHALI
NSE
12.15
0.04 (0.33%)
Prev Close
12.11
Open Price
12.21
Volume
123,345
Today Low / High
12 / 12.49
52 WK Low / High
10.3 / 24.91
Range
12 - 13
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 12.15, with a change of 0.04 (0.33031%). The expected target range on the NSE is between 12 - 13. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
08 Aug
12.50
-1.36%
07 Aug
13.00
-3.54%
06 Aug
12.33
5.19%
05 Aug
12.48
-1.28%
04 Aug
12.90
-3.49%
01 Aug
12.26
3.59%
31 Jul
12.51
-1.36%
30 Jul
12.54
-0.88%
29 Jul
12.30
0.16%
28 Jul
12.39
-0.89%
25 Jul
12.55
-1.27%
24 Jul
12.61
-0.56%
23 Jul
12.74
-1.26%
22 Jul
13.20
-4.24%
21 Jul
12.65
3.95%
Vaishali Pharma Limited Graph
Vaishali Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vaishali Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 12.15 | 12.27 | 11.04 - 13.50 |
| 12.39 | 9.91 - 14.87 | ||
| 12.51 | 8.76 - 16.27 | ||
| Bearish Scenario | 12.15 | 12.03 | 10.83 - 13.23 |
| 11.91 | 9.53 - 14.29 | ||
| 11.79 | 8.25 - 15.32 |
Overview of Vaishali Pharma Limited
ISIN
INE972X01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
607,941
Market Cap
1,321,677,360
Last Dividend
0
Official Website
IPO Date
2017-08-22
DCF Diff
20.36
DCF
-9
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 99.03 Cr | 88.74 Cr | 10.29 Cr | 0.1039 | 0.00 Cr | 0.00 Cr | -0.40 Cr | 0.82 Cr | 0.56 | 3.30 Cr | 0.0083 |
| 2024-03-31 | 86.28 Cr | 74.42 Cr | 11.86 Cr | 0.1375 | 0.00 Cr | 0.55 Cr | 6.34 Cr | 0.72 Cr | 0.57 | 3.17 Cr | 0.0083 |
| 2023-03-31 | 69.66 Cr | 54.68 Cr | 14.99 Cr | 0.2151 | 0.00 Cr | 0.38 Cr | 8.87 Cr | 6.60 Cr | 6.26 | 11.36 Cr | 0.0948 |
| 2022-03-31 | 71.54 Cr | 63.50 Cr | 8.04 Cr | 0.1123 | 0.00 Cr | 0.42 Cr | 6.43 Cr | 4.02 Cr | 3.82 | 8.64 Cr | 0.0562 |
| 2021-03-31 | 52.31 Cr | 46.15 Cr | 6.16 Cr | 0.1177 | 0.00 Cr | 0.26 Cr | 2.22 Cr | 1.05 Cr | 0.99 | 4.44 Cr | 0.0200 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.84 Cr | 109.84 Cr | 44.93 Cr | 64.9161 Cr | 12.32 Cr | 10.48 Cr | 4.81 Cr | 1.16 Cr | 0.00 Cr | 0.00 Cr | 2.37 Cr | 40.0529 Cr |
| 2024-03-31 | 1.58 Cr | 79.96 Cr | 37.12 Cr | 42.8394 Cr | 12.61 Cr | 11.91 Cr | 10.35 Cr | 1.46 Cr | 2.72 Cr | 0.00 Cr | 0.43 Cr | 33.0820 Cr |
| 2023-03-31 | 0.53 Cr | 78.91 Cr | 38.38 Cr | 40.5312 Cr | 14.74 Cr | 14.21 Cr | 3.05 Cr | 1.80 Cr | 2.31 Cr | 0.00 Cr | 1.64 Cr | 32.0780 Cr |
| 2022-03-31 | 1.16 Cr | 81.62 Cr | 55.27 Cr | 26.3542 Cr | 20.81 Cr | 19.65 Cr | 0.63 Cr | 0.90 Cr | 4.37 Cr | 0.00 Cr | 1.08 Cr | 51.9369 Cr |
| 2021-03-31 | 0.31 Cr | 86.12 Cr | 63.70 Cr | 22.4186 Cr | 17.85 Cr | 17.54 Cr | 0.59 Cr | 0.97 Cr | 2.90 Cr | 0.00 Cr | 1.08 Cr | 59.2605 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -19.4314 Cr | -0.2916 Cr | 19.9877 Cr | -19.7360 Cr | 0.0000 Cr | 1.8429 Cr | -0.3046 Cr | 0.8173 Cr | -0.9502 Cr | 0.0000 Cr | -4.4304 Cr |
| 2024-03-31 | 0.8067 Cr | 1.2027 Cr | 0.3225 Cr | 0.2711 Cr | 0.5936 Cr | 1.5783 Cr | -0.1110 Cr | 0.7189 Cr | -1.0539 Cr | 0.0000 Cr | 2.6704 Cr |
| 2023-03-31 | 1.0797 Cr | 0.2821 Cr | -1.7324 Cr | 0.7825 Cr | -0.3706 Cr | 0.9847 Cr | -0.2972 Cr | 8.8453 Cr | -4.5040 Cr | 0.0000 Cr | -2.4211 Cr |
| 2022-03-31 | 1.3186 Cr | -0.8468 Cr | 0.4175 Cr | 0.4538 Cr | 0.8893 Cr | 1.3553 Cr | -0.8648 Cr | 5.7284 Cr | 3.1880 Cr | 0.0000 Cr | -0.0407 Cr |
| 2021-03-31 | 2.0111 Cr | -0.1103 Cr | -1.8116 Cr | 1.8851 Cr | 0.0892 Cr | 0.4660 Cr | -0.1260 Cr | 1.4045 Cr | 0.9376 Cr | 0.0000 Cr | 0.2919 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 32.25 Cr | 31.51 Cr | 0.74 Cr | 0.0229 | -6.16 Cr | -4.29 Cr | -2.92 | -5.04 Cr | -0.1331 |
| 2024-12-31 | 27.91 Cr | 23.74 Cr | 4.18 Cr | 0.1497 | 3.55 Cr | 1.44 Cr | 0.98 | 1.31 Cr | 0.0517 |
| 2024-09-30 | 20.79 Cr | 16.80 Cr | 3.98 Cr | 0.1916 | 2.30 Cr | 1.97 Cr | 1.55 | 3.13 Cr | 0.0947 |
| 2024-06-30 | 18.08 Cr | 15.20 Cr | 2.88 Cr | 0.1594 | 2.22 Cr | 1.70 Cr | 1.34 | 2.77 Cr | 0.0940 |
| 2024-03-31 | 32.40 Cr | 33.09 Cr | -0.69 Cr | -0.0213 | -6.92 Cr | -4.68 Cr | -4.37 | -5.88 Cr | -0.1445 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.84 Cr | 0.00 Cr | 1.84 Cr | 46.72 Cr | 4.81 Cr | 104.48 Cr | 1.16 Cr | 109.84 Cr | 44.93 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -67.76 Cr |
| 2024-09-30 | 1.02 Cr | 28.31 Cr | 29.33 Cr | 0.00 Cr | 1.90 Cr | 98.39 Cr | 1.31 Cr | 103.95 Cr | 36.19 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 1.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -42.84 Cr |
| 2024-03-31 | 1.58 Cr | 1.85 Cr | 1.58 Cr | 61.87 Cr | 10.35 Cr | 74.52 Cr | 1.46 Cr | 79.96 Cr | 37.12 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1.44 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -4.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 2.11 Cr | 0.25 Cr | 0.00 Cr | 0.00 Cr | 0.25 Cr | 0.67 Cr | 0.43 Cr | 0.00 Cr | 0.25 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2024-10-15 | October 15, 24 | 5:1 |
| 2019-10-25 | October 25, 19 | 8:5 |
| 2019-10-17 | October 17, 19 | 8:5 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,640.90 | ₹3,936,978,552,000.00 | ₹1,313,620.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,100.50 | ₹1,619,493,634,500.00 | ₹394,932.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,617.80 | ₹1,224,426,321,000.00 | ₹287,405.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,253.40 | ₹1,043,245,022,805.00 | ₹1,191,889.00 |
| Mankind Pharma Limited | MANKIND | ₹2,466.00 | ₹1,017,789,122,160.00 | ₹376,033.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.60 | ₹994,758,978,000.00 | ₹1,911,246.00 |
| Lupin Limited | LUPIN | ₹1,989.80 | ₹908,835,180,600.00 | ₹875,748.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,388.50 | ₹644,276,002,500.00 | ₹899,623.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,078.20 | ₹626,220,716,400.00 | ₹444,368.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,029.30 | ₹572,670,489,300.00 | ₹466,363.00 |
| Laurus Labs Limited | LAURUSLABS | ₹863.15 | ₹465,949,948,750.00 | ₹2,817,579.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹986.05 | ₹377,230,198,238.00 | ₹177,879.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,364.60 | ₹346,204,478,400.00 | ₹113,365.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,671.70 | ₹333,791,511,200.00 | ₹40,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,715.50 | ₹268,163,529,000.00 | ₹62,276.00 |
| Piramal Enterprises Limited | PEL | ₹1,127.20 | ₹255,511,441,600.00 | ₹243,681.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,501.60 | ₹243,978,466,400.00 | ₹325,967.00 |
| Eris Lifesciences Limited | ERIS | ₹1,674.80 | ₹228,119,483,600.00 | ₹42,022.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,416.50 | ₹210,412,500,000.00 | ₹34,705.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹941.00 | ₹184,965,783,000.00 | ₹25,900.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,077.50 | ₹171,625,277,500.00 | ₹132,577.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,018.00 | ₹167,019,638,200.00 | ₹23,483.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,156.90 | ₹163,949,635,730.00 | ₹164,102.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹904.25 | ₹161,960,217,500.00 | ₹516,819.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹460.35 | ₹111,701,165,400.00 | ₹778,530.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,182.50 | ₹102,625,790,500.00 | ₹13,202.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹906.20 | ₹88,618,113,580.00 | ₹114,891.00 |
| Strides Pharma Science Limited | STAR | ₹867.30 | ₹79,941,382,710.00 | ₹568,013.00 |
| FDC Limited | FDC | ₹483.20 | ₹78,669,792,000.00 | ₹76,497.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹790.45 | ₹71,642,135,379.00 | ₹1,229,147.00 |
| Innova Captab Limited | INNOVACAP | ₹902.00 | ₹51,616,886,860.00 | ₹24,559.00 |
| Suven Life Sciences Limited | SUVEN | ₹232.25 | ₹50,647,686,500.00 | ₹235,893.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.28 | ₹46,172,990,160.00 | ₹192,243.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹488.05 | ₹44,544,323,500.00 | ₹79,719.00 |
| Sequent Scientific Limited | SEQUENT | ₹171.51 | ₹42,934,955,850.00 | ₹221,470.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹768.10 | ₹38,957,340,710.00 | ₹102,241.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,281.60 | ₹37,735,382,400.00 | ₹9,674.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹513.80 | ₹36,174,500,040.00 | ₹45,592.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹356.70 | ₹35,769,162,600.00 | ₹36,115.00 |
| Hikal Limited | HIKAL | ₹255.65 | ₹31,521,900,650.00 | ₹589,191.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹605.30 | ₹29,147,010,900.00 | ₹54,573.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹93.23 | ₹27,365,522,210.00 | ₹1,598,864.00 |
| Indoco Remedies Limited | INDOCO | ₹293.70 | ₹27,093,208,230.00 | ₹138,144.00 |
| Alembic Limited | ALEMBICLTD | ₹105.19 | ₹27,010,898,475.00 | ₹451,825.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹47.31 | ₹25,923,703,740.00 | ₹3,167,804.00 |
Key Executives
Chairman & MD
Mr. Atul Arvind Vasani
Gender: male
Year Born: 1964
Company Secretary & Compliance Officer
Ms. Vishwa Bipinbhai Mekhia
Gender: female
Year Born: 1991
Whole Time Director
Ms. Jagruti Atul Vasani
Gender: female
Year Born: 1966
Executive Director
Mr. Dewansh Ajay Vasani
Gender: male
Year Born: 1995
Chief Executive Officer
Mr. Hemanth Damodar Pathak
Gender: male
Year Born: 1961
Chief Operating Officer
Ms. Priyanka Atul Vasani
Gender: female
Year Born: 1992
FAQs about Vaishali Pharma Limited
Who is the CEO of the company?
The CEO is Hemanth Damodar Pathak.
What is the current market price of the stock?
The current price is ₹12.33.
What is the 52-week price range?
The range is ₹10.3-24.91.
What is the market capitalization of the company?
The market capitalization is ₹132.17 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 130.68.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Vaishali Pharma Limited (ISIN: INE972X01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹132.17 crores and an average daily volume of 607,941 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.